VCAM1 and rheumatoid arthritis: In addition, GZFL had improving effects on articular symptoms and endothelial dysfunction in rheumatoid arthritis (RA) patients by reducing plasma levels of soluble vascular cell adhesion molecule-1 (sVCAM)-1 and lipid peroxide (LPO) [78].